Literature DB >> 17475980

Adolescent adherence to oral therapy for leukemia: a focus group study.

Tara Malbasa1, Eric Kodish, Sheila Judge Santacroce.   

Abstract

This secondary qualitative analysis of extant focus group data was performed to develop an understanding of suboptimal adherence to 6-mercaptopurine therapy in adolescents with acute lymphoblastic leukemia. Six participants, aged 16 to 23 years at the time of data collection, were interviewed about their adherence to oral maintenance chemotherapy during their treatment for acute lymphoblastic leukemia. The primary aim of the study was to understand the role of adolescent development in adolescents' perception of adherence to therapy. The secondary aim was to understand how factors other than development, including the features of the disease such as its chronic nature and family involvement, can affect treatment adherence to 6-mercaptopurine. Four broad themes emerged as critical elements in adolescent adherence to oral maintenance therapy: a desire for normalcy, egocentrism, concrete thinking, and parental involvement. Incorporation of these themes into clinical practice with adolescents may help increase adherence and improve clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475980     DOI: 10.1177/1043454206298695

Source DB:  PubMed          Journal:  J Pediatr Oncol Nurs        ISSN: 1043-4542            Impact factor:   1.636


  10 in total

1.  Medical and psychosocial associates of nonadherence in adolescents with cancer.

Authors:  Stephanie E Hullmann; Lauren D Brumley; Lisa A Schwartz
Journal:  J Pediatr Oncol Nurs       Date:  2014-11-03       Impact factor: 1.636

2.  A grounded theory of the process of adherence to oral chemotherapy in Hispanic and caucasian children and adolescents with acute lymphoblastic leukemia.

Authors:  Wendy Landier; Cynthia B Hughes; Evelyn R Calvillo; Nancy L R Anderson; Deborah Briseño-Toomey; Leticia Dominguez; Alex M Martinez; Cara Hanby; Smita Bhatia
Journal:  J Pediatr Oncol Nurs       Date:  2011-06-08       Impact factor: 1.636

3.  Psychosocial and emotional adjustment for children with pediatric cancer and their primary caregivers and the impact on their health-related quality of life during the first 6 months.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Wen-Jiun Chou; Chao-Ping Yang; Tang-Her Jaing; Iou-Jih Hung; Hwey-Fang Liang; Hsuan-Rong Huang; Yu-Shu Huang
Journal:  Qual Life Res       Date:  2012-04-22       Impact factor: 4.147

4.  Recruitment strategies and rates of a multi-site behavioral intervention for adolescents and young adults with cancer.

Authors:  Verna L Hendricks-Ferguson; Brooke O Cherven; Debra S Burns; Sharron L Docherty; Celeste R Phillips-Salimi; Lona Roll; Kristin A Stegenga; Molly Donovan Stickler; Joan E Haase
Journal:  J Pediatr Health Care       Date:  2012-06-02       Impact factor: 1.812

5.  Role of the nurse in patient education and follow-up of people receiving oral chemotherapy treatment: an international survey.

Authors:  Sultan Kav; Judi Johnson; Cynthia Rittenberg; Paz Fernadez-Ortega; Tarja Suominen; Pia Riis Olsen; Elisabeth Patiraki; Davina Porock; Annette Dahler; Jolanta Toliusiene; Dusanka Tadic; Pongpak Pittayapan; Vijay Roy; Qi Wang; Meric Colak; Hanan Saca-Hazboun; David Makumi; Ilana Kadmon; Sarah Ben Ami; Elsie Anderson; Rebecca Clark-Snow
Journal:  Support Care Cancer       Date:  2008-01-16       Impact factor: 3.603

6.  Surviving with lung cancer: medication-taking and oral targeted therapy.

Authors:  Karen E Wickersham; Mary Beth Happ; Catherine M Bender; Sandra J Engberg; Ahmad Tarhini; Judith A Erlen
Journal:  Geriatr Nurs       Date:  2014 Mar-Apr       Impact factor: 2.361

7.  The 2009-2013 research agenda for oncology nursing.

Authors:  Ann M Berger; Barbara Cochrane; Sandra A Mitchell
Journal:  Oncol Nurs Forum       Date:  2009-09       Impact factor: 2.172

8.  Tyrosine kinase inhibitors in patients with chronic myelogeneous leukemia: defining the role of social risk factors and non-adherence to treatment.

Authors:  Lucas M Okumura; Valquíria D Antunes; Karina S Aguiar; Tatiane Farias; Vânia M Andrzejevski; Vaneuza M Funke
Journal:  Pharm Pract (Granada)       Date:  2015-06-15

9.  Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.

Authors:  Lynne Lennard; Cher S Cartwright; Rachel Wade; Ajay Vora
Journal:  Br J Haematol       Date:  2015-05-05       Impact factor: 6.998

10.  "Keeping the Boogie Man Away": Medication Self-Management among Women Receiving Anastrozole Therapy.

Authors:  Karen Wickersham; Mary Beth Happ; Catherine M Bender
Journal:  Nurs Res Pract       Date:  2012-12-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.